Capital International Investors 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 12:52 pm Sale | 2026-03-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Capital International Investors | 2,013,285 3.200% | -1,095,940 (-35.25%) | Filing |
| 2025-08-13 12:49 pm Purchase | 2025-06-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Capital International Investors | 3,109,225 5.600% | 3,109,225 (New Position) | Filing |